文献速递免疫规划传染病防控与疫情报告

2004-2016年中国扩大免疫规划使用甲肝减毒活疫苗和灭活疫苗的影响

The impact of expanded program on immunization with live attenuated and inactivated Hepatitis A vaccines in China, 2004-2016.
PubMed 文献 · Vaccine · 2018-01-01

2008年起中国将甲肝减毒活疫苗(L-HepA)和灭活疫苗(I-HepA)纳入扩大免疫规划(EPI),按地区分别接种。研究回顾2004-2016年甲肝流行病学数据,发现2008-2016年目标儿童甲肝疫苗覆盖率98.8%,L-HepA地区发病率下降78.0%,I-HepA地区下降82.3%,无显著差异。

要点

  • 2008-2016年目标儿童甲肝疫苗总覆盖率98.8%,I-HepA地区99.6%,L-HepA地区98.7%。
  • L-HepA地区甲肝发病率下降78.0%,I-HepA地区下降82.3%,两者无显著差异。
  • 两个地区所有年龄组甲肝发病率均大幅下降。

核心结论

  • 研究提示,I-HepA和L-HepA覆盖率均高的EPI对中国甲肝发病率产生了积极影响。

研究设计与样本

  • 基于国家法定传染病报告系统(NNDRS)回顾2004-2016年甲肝流行病学,并从儿童免疫信息管理系统(CIIMS)收集L-HepA和I-HepA覆盖率数据,按使用疫苗类型划分地区比较覆盖率与发病率随时间的变化。

主要发现

  • 2008-2016年目标儿童甲肝疫苗覆盖率为98.8%,其中I-HepA地区99.6%,L-HepA地区98.7%。
  • L-HepA地区甲肝发病率下降78.0%,I-HepA地区下降82.3%,两者无显著差异。
  • 两个地区所有年龄组甲肝发病率均大幅下降。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Since 2008, two types of hepatitis A (HepA) vaccines were integrated into the expanded program on immunization (EPI) in China. Children were given either one dose of live attenuated HepA (L-HepA) or two doses of inactivated HepA (I-HepA), depending on geographic regions. We sought to evaluate the impact of the EPI on HepA incidence in China. METHODS: We reviewed the epidemiology of HepA during 2004-2016 from National Notifiable Disease Reporting System (NNDRS). We collected data of L-HepA and I-HepA coverage from Children Immunization Information Management System (CIIMS). Based on the regions where two types of HepA vaccines were used, the coverage and incidence of HepA were compared over time. RESULTS: In 2008-2016, the HepA vaccine coverage was 98.8% among target children, with 99.6% in I-HepA region and 98.7% in L-HepA region. HepA incidence declined by 78.0% and 82.3% in L-HepA region and I-HepA region, respectively, without significant difference. Dramatic decline were seen in all age groups of both regions. CONCLUSION: The study suggests that the EPI, with high coverage for both I-HepA and L-HepA, had positive impact on HepA incidence in China.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Sun X, Wang F, Zheng H, et al. The impact of expanded program on immunization with live attenuated and inactivated Hepatitis A vaccines in China, 2004-2016. Vaccine. 2018. PMID: 29398275. doi:10.1016/j.vaccine.2018.01.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。